Coronavirus Vaccine Serum Institute Of India
-
{
- All
- News
-
"Respected POTUS...": Serum Institute's Adar Poonawalla Makes A Request
Serum Institute CEO Adar Poonawalla on Friday urged US President Joe Biden to lift an embargo on export of raw materials needed for the production of the Covishield coronavirus vaccine in India
-
South Africa To Get 1.5 Million Vaccines From Serum Institute Of India
South Africa's health ministry said on Thursday that the country would get 1.5 million vaccines from the Serum Institute of India (SII), with a million coming in January and the remainder the following month.
-
Maharashtra Firm Files Case Against Serum Institute Over "Covishield" Trademark
A civil court in Pune on Tuesday issued a notice to the Serum Institute of India (SII) on a suit filed by a pharmaceutical products manufacturer and seller seeking to restrain the former from using trademark ''Covishield'' or any other similar names for its upcoming COVID-19 vaccine.
-
India To Get 100 Million Oxford Vaccine Shots By December: Adar Poonawalla
The world's largest vaccine maker is ramping up production of AstraZeneca's Covid-19 shot, aiming to have 100 million doses ready by December for an inoculation drive that could begin across India that same month.
-
Covishield Vaccine: Phase II Human Trial Of Oxford COVID-19 Vaccine Candidate Begins In Pune
The Phase II human clinical trial of the Oxford COVID-19 vaccine candidate, being manufactured by the Pune-based Serum Institute of India (SII), began at a medical college and hospital in the city today.
-
"Respected POTUS...": Serum Institute's Adar Poonawalla Makes A Request
Serum Institute CEO Adar Poonawalla on Friday urged US President Joe Biden to lift an embargo on export of raw materials needed for the production of the Covishield coronavirus vaccine in India
-
South Africa To Get 1.5 Million Vaccines From Serum Institute Of India
South Africa's health ministry said on Thursday that the country would get 1.5 million vaccines from the Serum Institute of India (SII), with a million coming in January and the remainder the following month.
-
Maharashtra Firm Files Case Against Serum Institute Over "Covishield" Trademark
A civil court in Pune on Tuesday issued a notice to the Serum Institute of India (SII) on a suit filed by a pharmaceutical products manufacturer and seller seeking to restrain the former from using trademark ''Covishield'' or any other similar names for its upcoming COVID-19 vaccine.
-
India To Get 100 Million Oxford Vaccine Shots By December: Adar Poonawalla
The world's largest vaccine maker is ramping up production of AstraZeneca's Covid-19 shot, aiming to have 100 million doses ready by December for an inoculation drive that could begin across India that same month.
-
Covishield Vaccine: Phase II Human Trial Of Oxford COVID-19 Vaccine Candidate Begins In Pune
The Phase II human clinical trial of the Oxford COVID-19 vaccine candidate, being manufactured by the Pune-based Serum Institute of India (SII), began at a medical college and hospital in the city today.
